<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29141583</article-id>
<article-id pub-id-type="pmc">5688748</article-id>
<article-id pub-id-type="publisher-id">486</article-id>
<article-id pub-id-type="doi">10.1186/s12881-017-0486-4</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Clinical and molecular genetic characterization of familial <italic>MECP2</italic> duplication syndrome in a Chinese family</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Xiaoyan</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Xie</surname>
<given-names>Hua</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Qian</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xiongying</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yi</surname>
<given-names>Zhaoshi</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Erzhen</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Ting</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Jian</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhong</surname>
<given-names>Jianmin</given-names>
</name>
<address>
<phone>+86-0791-86813639</phone>
<email>zhongjm@163.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0536-1553</contrib-id>
<name>
<surname>Chen</surname>
<given-names>Xiaoli</given-names>
</name>
<address>
<phone>+86-010-85695539</phone>
<email>cxlwx@sina.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.459437.8</institution-id><institution>Department of Neurology, </institution><institution>Jiangxi Children’s Hospital, </institution></institution-wrap>Yangming Road, Donghu District, Nanchang, 330006 China </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1771 7032</institution-id><institution-id institution-id-type="GRID">grid.418633.b</institution-id><institution>Beijing Municipal Key Laboratory of Child Development and Nutriomics, </institution><institution>Capital Institute of Pediatrics, </institution></institution-wrap>Room 616, NO. 2, Yabao Road, Chaoyang District, Beijing, 100020 China </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1771 7032</institution-id><institution-id institution-id-type="GRID">grid.418633.b</institution-id><institution>Department of Medical Genetics, </institution><institution>Capital Institute of Pediatrics, </institution></institution-wrap>Beijing, China </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.459434.b</institution-id><institution>Department of Neurology, </institution><institution>Affiliated Children’s Hospital of Capital Institute of Pediatrics, </institution></institution-wrap>Beijing, China </aff>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.415869.7</institution-id><institution>Department of Laboratory Medicine, Shanghai Children’s Medical Center, </institution><institution>Shanghai Jiaotong University School of Medicine, </institution></institution-wrap>Shanghai, China </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>11</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>18</volume>
<elocation-id>131</elocation-id>
<history>
<date date-type="received">
<day>17</day>
<month>7</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>24</day>
<month>10</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2017</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p id="Par1">Chromosomal duplication at the Xq28 region including the <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK1284/"><italic>MECP2</italic></ext-link> gene, share consistent clinical phenotypes and a distinct facial phenotype known as <italic>MECP2</italic> duplication syndrome. The typical clinical features include <ext-link ext-link-type="uri" xlink:href="http://compbio.charite.de/hpoweb/showterm?id=HP:0008947">infantile hypotonia</ext-link>, mild dysmorphic features, a broad range of neurodevelopmental disorders, recurrent infections, and progressive spasticity.</p>
</sec>
<sec>
<title>Methods</title>
<p id="Par2">This Chinese <italic>MECP2</italic> duplication syndrome family includes six patients (five males and one female), and four asymptomatic female carriers. Two kinds of chips including 4x180K CNV + SNP chip and custom 8x60K CNV chip were used to detect <italic>MECP2</italic> duplication, and then fluorescent in situ hybridization (FISH) analysis was performed to identify the exact copy number of <italic>MECP2</italic>. X-chromosome inactivation (XCI) analysis on AR gene was detected for all female family members, and the m<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">icrosatellite</ext-link> analysis on <italic>MECP2</italic> was used to validate the recombination event on <italic>MECP2</italic> region.</p>
</sec>
<sec>
<title>Results</title>
<p id="Par3">The affected male subjects presented with a broad range of neurodevelopmental symptoms (severe intellectual disability, developmental delay, seizure, language deficit, and autism spectrum disorder) as well as facial dysmorphism and other symptoms which were consistent with that of Western patients previous reported. Seizure is reported in Chinese patients for the first time. In addition, we validated three recombination events for the <italic>MECP2</italic>-duplication allele during maternal transmission due to X homologous recombination.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par4">We provided the largest known Chinese pedigree with <italic>MECP2</italic> duplication syndrome. The detailed clinical description and molecular genetic characterization in all affected family members further delineate the typical phenotype of this genomic disorder in Chinese population.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (10.1186/s12881-017-0486-4) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Clinical and molecular genetic characterization</kwd>
<kwd>Familial <italic>MECP2</italic> duplication syndrome</kwd>
<kwd>Genomic recombination</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution> the Capital Health Research and Development of Special </institution>
</funding-source>
<award-id>2014-2-1131</award-id>
<principal-award-recipient>
<name>
<surname>Chen</surname>
<given-names>Xiaoli</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>the National Nature Science Fund</institution>
</funding-source>
<award-id>81100841 and 81370708 to XLC</award-id>
<award-id>81401207</award-id>
<principal-award-recipient>
<name>
<surname>Xie</surname>
<given-names>Hua</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Xiaoli</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution>the advanced Personnel Training Program of Beijing Municipal Health Bureau to XLC</institution>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution>Beijing nova program interdisciplinary collaborative project to XLC </institution>
</funding-source>
<award-id>xxjc201717</award-id>
<principal-award-recipient>
<name>
<surname>Chen</surname>
<given-names>Xiaoli</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2017</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par15">X-linked intellectual disability (XLID) is a group of genetically heterogeneous diseases characterized by cognitive impairment and reduced adaptive skills [<xref ref-type="bibr" rid="CR1">1</xref>]. XLID can be caused by single nucleotide variants (SNVs) and/or copy number variants (CNVs) on the X chromosome [<xref ref-type="bibr" rid="CR2">2</xref>]. For example, the loss-of-function mutation of methyl-CpG-binding protein 2 gene (<italic>MECP2</italic>) contributes to Rett syndrome [<xref ref-type="bibr" rid="CR3">3</xref>], while the increased copy number of <italic>MECP2</italic> contributes to <italic>MECP2</italic> duplication syndrome [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par16">With the increased usage of chromosomal microarray or other techniques in clinical diagnostic laboratory, <italic>MECP2</italic> duplication can now be detected quickly. Up to 2015, more than 200 patients with <italic>MECP2</italic> duplication syndrome have been described [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. In China, microarray has been applied for clinical genetic diagnosis only in developed region since 2010 [<xref ref-type="bibr" rid="CR25">25</xref>–<xref ref-type="bibr" rid="CR27">27</xref>], the exact diagnosis yield of <italic>MECP2</italic> duplication in neurodevelopmental disorders is unknown. Only sporadic Chinese patient with <italic>MECP2</italic> duplication have been reported before. In this study, we reported familial <italic>MECP2</italic> duplication syndrome in a large Chinese family, in which four male patients and four asymptomatic females were confirmed as carrying <italic>MECP2</italic> duplication. Beside the typical neurodevelopmental symptoms such as severe intellectual disability, developmental delay, poor language skills, and autism spectrum disorder (ASD), the symptom generalized tonic–clonic seizure existed consistently in the four male patients. Major non-neurological symptoms, which include recurrent respiratory infections and constipation, existed in all affected male patients. As the third reported case of <italic>MECP2</italic> duplication syndrome in Chinese patients, the detailed neurodevelopmental trajectory and facial dysmorphism in this study will further delineate clinical description and molecular genetic characterization of <italic>MECP2</italic> duplication syndrome in Chinese. Of note, one male patient in this family was the fifth male patient ever reported to have survived past 25 years old [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>].</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Array comparative genomic hybridization (aCGH) analysis</title>
<p id="Par17">Genomic DNA was extracted from peripheral blood for all available family members using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany). The aCGH was performed according to previously published methods using Agilent Oligonucleotide Microarray [<xref ref-type="bibr" rid="CR28">28</xref>]. Raw chip data were analyzed via DNA CytoGenomics software (Agilent Technologies Inc., Palo Alto, CA). There are two kinds of aCGH used to detect <italic>MECP2</italic> duplication: 4x180K CNV + SNP chip [<xref ref-type="bibr" rid="CR28">28</xref>] and custom 8x60K CNV chip. The custom 8x60K CNV chip was designed in particular to detect any single genetic CNV on the known X-linked genes (90 genes) [<xref ref-type="bibr" rid="CR2">2</xref>]. For 8x60K CNV chip, there are 30,000 probes which were designed to cover the entire genome with an average of 30 kb between adjacent probes, allowing for the detections of 300-500 kb CNV on non-X chromosomes (the validation results had showed that most of recurrent neurodevelopmental disorder-related CNV can be detected from this customized chip. Under manuscript); meanwhile, high-density probes (10,000 probes) were designed for the genomic region of 90 X-linked genes. Then, the probes covering each exon of these X-linked genes were checked one-by-one, ensuring that each exonic region (the exon and its flanking 100 bp) contains at least one probe with an average 100 bp between adjacent probes. Finally, the X chromosome contained 35.57% (21347) of the whole genome probes, and the 90 X-linked genes contained 31.39% (18837) of whole genomic probes. 88% of the 1502 exons in the X-linked genes were covered by at least three probes, and 70% of the 1502 exons were covered by at least four probes. All designs were performed on Agilent SureDesign website (<ext-link ext-link-type="uri" xlink:href="https://earray.chem.agilent.com/suredesign/agilent.com">https://earray.chem.agilent.com/suredesign/agilent.com</ext-link>).</p>
</sec>
<sec id="Sec4">
<title>Multiplex Ligand-dependant probe amplification (MLPA) analysis and FISH analysis</title>
<p id="Par18">MLPA probemix P015 (MRC-Holland, Amsterdam, Holland) was used to test <italic>MECP2</italic> duplication in the remaining family members. Those who are not carrying <italic>MECP2</italic> duplication as confirmed by 244 K chip were chosen as controls. The data was analyzed by Genemarker V5.0.14 (SoftGenetics, State College, PA).</p>
<p id="Par19">In order to identify the exact copy number of <italic>MECP2</italic>, we performed FISH for the proband (III:16) by standard procedures using SureFISH Xq28 <italic>MECP2</italic> probe (spectrum green, Hg19, ChrX:153,286,406–153,368,945) and SureFISH Xq22.31 STS probe (spectrum red, Hg19, ChrX:7,137,093–7,272,886) (Agilent Technologies Inc., Palo Alto, CA).</p>
</sec>
<sec id="Sec5">
<title>X-chromosome inactivation (XCI) analysis on <italic>AR</italic> and the m<ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">icrosatellite</ext-link> analysis on <italic>MECP2</italic></title>
<p id="Par20">XCI was examined using androgen receptor (<italic>AR</italic>) methylation assay with minor modifications [<xref ref-type="bibr" rid="CR29">29</xref>]. The XCI patterns were classified as random (a ratio between 50:50 and 80:20) or skewed (a ratio higher than 80:20). Two aliquots of 500 ng of genomic DNA were incubated at 37 °C overnight, one with 20 units of the methylation-sensitive restriction enzyme HpaII (NEB, Beverly, USA) and the other without. Both products were then used as templates to amplify the (CAG)n small tandem repeat in exon 1 of <italic>AR</italic> gene.</p>
<p id="Par21">The <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">microsatellite</ext-link> 23 × GT within the <italic>MECP2</italic> gene region was chosen to differentiate the <italic>MECP2-</italic>duplication allele from the <italic>MECP2</italic>-normal allele. This assay was performed on all available family members. The sequence of forward primer used was FAM 5′-TGAGGACAGCCAGAAGGAGT-3′, and that of the reverse primer used was 5′-ACACCCCTTTCCTTTGTGTG-3′.</p>
<p id="Par22">The PCR products were separated according to size using 3730xl Genetic Analyzer (Applied Biosystems, Vernon Hills, Illinois, USA) and were analyzed by GeneMapper 4.0 software.</p>
<p id="Par23">The study was approved by the ethics committee of Capital Institute of Pediatrics and Jiangxi Children’s Hospital. Written informed consent was obtained from the patients’ guardian/parent/next of kin for the publication of this report and any accompanying images. Physical and neurological evaluations were completed by a neurologist and a developmental specialist (i.e. QC, JMZ). IQ was measured by Wechsler Intelligence Scale for Children (WISC), DSM-V was used by the neurologist for ASD diagnosis.</p>
</sec>
</sec>
<sec id="Sec6">
<title>Results</title>
<sec id="Sec7">
<title>Clinical information</title>
<p id="Par24">This Chinese family includes a total of six patients with neurodevelopment disorders (five males and one female) from four generations (Fig. <xref ref-type="fig" rid="Fig1">1a</xref>). Their physical and neurodevelopmental status were evaluated by a neurologist or a clinical geneticist (Table <xref ref-type="table" rid="Tab1">1</xref>). Four male patients exhibited consistent facial dysmorphism (Fig. <xref ref-type="fig" rid="Fig1">1b</xref>). ASD was diagnosed in four male patients (III:6, III:16, IV:1, IV:2) based on the DMS-V criteria.<fig id="Fig1"><label>Fig. 1</label><caption><p>The Chinese family with <italic>MECP2</italic> duplication syndrome. <bold>a</bold> Pedigree of the Chinese family. <bold>b</bold> Facial features of the affected male patients (a. III:16 at 11 years and 2 months old. b. III:6 at 24 years old. c. IV:2 at 2 years and 10 months old. d. IV:1 at 14 years and 8 months old). They show consistent and typical facial features of <italic>MECP2</italic> duplication syndrome, such as midface hypoplasia, long face, down-slanting palpebral fissures, epicanthus, small mouth, jaw protrusion, low-set ears, and large ear lobe and crease</p></caption><graphic id="MO1" xlink:href="12881_2017_486_Fig1_HTML"></graphic></fig>
<table-wrap id="Tab1"><label>Table 1</label><caption><p>The summary of clinical features of the male patients with familial <italic>MECP2</italic> duplication</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"></th><th colspan="6">Our cases</th><th colspan="2">Literature review (male patients)</th></tr><tr><th>III:6</th><th>III:15</th><th>III:16</th><th>IV:1</th><th>IV:2</th><th>%</th><th>179</th><th>%</th></tr></thead><tbody><tr><td>Age of enrolled</td><td>25 years</td><td>NA</td><td>11 years and 2 months</td><td>14 years and 6 months</td><td>2 years and 6 months</td><td></td><td></td><td></td></tr><tr><td>Age of death</td><td>–</td><td>16 years</td><td>–</td><td>14 years and 8 months</td><td>–</td><td></td><td></td><td></td></tr><tr><td>Intellectual disability</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td align="char" char=".">100%</td><td align="char" char="/">159/160</td><td align="char" char=".">99.4%</td></tr><tr><td>Delayed milestones</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Age of head control</td><td>NA</td><td>7–8 months</td><td>7–8 months</td><td>3–4 months</td><td>3–4 months</td><td></td><td></td><td></td></tr><tr><td>Age of independent sitting</td><td>over 2 years</td><td>2 years</td><td>2 years</td><td>8 months</td><td>8 months</td><td></td><td></td><td></td></tr><tr><td>Age learned to walk</td><td>over 2 years</td><td>over 2 years</td><td>over 2 years</td><td>3 years</td><td>1 year and 6 months</td><td></td><td></td><td></td></tr><tr><td>Feed difficulty</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td></td><td></td><td></td></tr><tr><td>Seizure</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td align="char" char=".">80%</td><td align="char" char="/">97/162</td><td align="char" char=".">59.9%</td></tr><tr><td>Age for first seizure</td><td>7 years</td><td>3 years</td><td>2 years</td><td>10 years</td><td>no</td><td></td><td></td><td></td></tr><tr><td>Types of seizures</td><td>generalized tonic-clonic seizure, myoclonic seizure, nodding attack and drop attack</td><td>generalized tonic–clonic seizures</td><td>generalized tonic–clonic seizures</td><td>generalized tonic-clonic seizure, myoclonic seizure, nodding attack and drop attack</td><td>no</td><td></td><td></td><td></td></tr><tr><td>Hypotonia</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td align="char" char=".">100%</td><td align="char" char="/">141/151</td><td align="char" char=".">93.4%</td></tr><tr><td>ASD or autistic feature</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td align="char" char=".">100%</td><td align="char" char="/">30/41</td><td align="char" char=".">73.2%</td></tr><tr><td>Poor or no eye-to-eye Contact</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Delayed develop peer relationships</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Speech lack or delay</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Stereotyped hand Movement</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Lack of social or Emotional reciprocity</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td></td><td></td><td></td></tr><tr><td>Recurrent respiratory Infection</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td align="char" char=".">80%</td><td align="char" char="/">114/157</td><td align="char" char=".">72.6%</td></tr><tr><td>Constipation</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td align="char" char=".">100%</td><td align="char" char="/">39/103</td><td align="char" char=".">37.9%</td></tr><tr><td>
<italic>MECP2</italic> duplication diagnosis</td><td>MLPA</td><td>clinical feature and family-based linkage analysis</td><td>array CGH</td><td>array CGH</td><td>MLPA</td><td></td><td></td><td></td></tr></tbody></table></table-wrap>
</p>
<p id="Par25">III:16 was the 11-year-old proband born to a healthy non-consanguineous couple and was delivered with polyhydramnios (birth weight was 3900 g, &gt; 90 percentile). He was noted to exhibit developmental delay at the age of 5 months. He raised his head at 8 months old, walked independently at 2 years old, and uttered “Mama” or “Papa” at 3 years old. He had been referred to Jiangxi Children’s Hospital several times due to global developmental delay since he was 6 months old, and then transferred to the Affiliated Children’s Hospital of Capital Institute of Pediatrics at 11 years old for final diagnosis/treatment. Thus far, he cannot speak any comprehensible phrase or run steadily and eye contact is absent. Central hypotonia was noticed at birth. He developed generalized tonic-clonic seizure at 2 years age, which occurs 1–3 times a year and 3–4 min per attack. Developmental regression was noticed after the first seizure attack. His facial dysmorphic features include midfacial hypoplasia, long face, down-slanting palpebral fissures, epicanthus, small mouth, jaw protrusion, low-set ears, and large ear lobes and creases. He experienced recurrent respiratory infections and refractory constipation with bowel movement every 2–4 days. A brain MRI demonstrated corpus callosum dysplasia. Stereotyped movement (hand flapping, looking at his hands, and biting his fingers) was noticed during clinical interview.</p>
<p id="Par26">III:15 was an older brother of III:16. His delivery and birth was generally normal except for polyhydramnios and low birth weight (2000 g, &lt; 3 centile). He showed developmental delay since he was 7 months old. He could not say “Mama” or “Papa” even after 3 years old. Severe speech deficit was diagnosed at 7 years old because single words were absolutely absent. Since the age of 3, he had suffered from generalized tonic–clonic seizures frequently. His parents recalled that he developed schizophrenia-like symptom (no contact with family members and repetitive behavior) after multiple onsets of seizure. Beside the neurodevelopmental symptoms, truncal ataxia and unusual gestures were noticed by his parents and recorded in his medical history. He died of a central nervous system infection at 16 years old. His blood sample was not available for genetic testing.</p>
<p id="Par27">III:6 was born to a non-consanguineous couple, and had normal gestation, birth, and neonatal development (birth weight was 3500 g, &gt; 75 percentile). He presented with developmental delay at 7 months old. He sat and walked steadily at 2 years old, and uttered “Mama” and “Papa” at 5 years old. He suffered from multiple types of seizures (generalized tonic-clonic seizure, myoclonic seizure, nodding attack and drop attack) frequently after 7 years old, and his language ability regressed after the seizure attacks. Stereotyped movement, unusual gestures, hypotonia, and similar dysmorphic features as III:16 were also noticed. Recurrent respiratory infections and constipation occurred occasionally during the first 10 years. He was 25 years old at the time of our last clinical interview, and he had elementary self-care ability. However, he cannot communicate socially with others, and lacked eye-contact. His IQ scores was less than 30.</p>
<p id="Par28">IV:1 was the first boy born to non-consanguineous parents after normal gestation, delivery, and neonatal period (birth weight was 4000 g, &gt; 95 percentile). He showed developmental delay since 12 months old; he could walk independently and babble some non-conscious words at 3 years old. He also suffered from hypotonia, seizures, constipation and recurrent respiratory infections as the above affected patients did. The types of seizures included generalized tonic-clonic seizure, myoclonic seizure, nodding attack and drop attack. Developmental regression was noticed after the seizures. A brain MRI demonstrated hypomyelination in the periventricular white matter. He presented with stereotyped movements and eye contact was absent. At the age of 14 years and 6 months, he suffered from a central nervous system infection and died 2 months later as a result. All medical evaluations and genetic testing have been completed before his death.</p>
<p id="Par29">IV:2 was a younger brother of IV:1 with normal gestation and birth (birth weight was 3500 g, &gt; 75 percentile). He showed developmental delay since he was 12 months old. For example, he walked with an ataxic gait after 2 years old. Now, at 2 year and 6 months old, he only can say “Mama” and “Papa”. Like his brother and the other male patients in his family, he presented with stereotyped movements, little eye contact, hypotonia, and constipation However, he did not suffer from recurrent respiratory infections, developmental regression or seizures. Young age is the possible explanation. A brain MRI demonstrated periventricular leukodystrophy. The electroencephalogram was normal.</p>
<p id="Par30">IV:4 was a girl born to non-consanguineous parents at normal birth (birth weight was 3000 g, &gt; 25 percentile). She died of severe pneumonia and myocarditis at the age of 2. According to her parents, during neonatal period, she had a fever with temperature over 39 °C, and her development was significantly delayed compared to that of age-matched peers. She had not raised her head, sit or walked independently at all until her death. Central hypotonia, recurrent respiratory infections and absence of eye contact were recorded in her medical history. She has experienced generalized tonic-clonic seizures since she was 3 months old. A brain MRI before her death demonstrated diffuse low density. No blood sample was available for genetic testing.</p>
</sec>
<sec id="Sec8">
<title>Familial <italic>MECP2</italic> duplication is identified by aCGH, MLPA and FISH analysis</title>
<p id="Par31">The high-density array (4 × 180 K) was used for III:16 only. He showed a clinically significant 550 kb duplication on the Xq28 region (chrX:153,056,054–153,606,328 in the genome build hg19, Fig. <xref ref-type="fig" rid="Fig2">2a</xref>). This region contains 24 genes (including <italic>MECP2</italic>, <italic>IRAK1, L1CAM, AVPR2, NAA10, HCFC1,</italic> etc). Afterwards, the custom 8 × 60 K array was used to test for the same <italic>MECP2</italic> duplication in the others. The custom array ultimately showed that the male patient (IV:1) also harbored the <italic>MECP2</italic> duplication (Fig. <xref ref-type="fig" rid="Fig2">2b</xref>). Some female family members (II:11, III:2 and III:12) harbored the duplication as well, but others (II:5, II:7, II:9 and III:5) did not. MLPA results confirmed the duplication in patients III:6 and IV:2 and in family member II:3 (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Figure S1). In total, four female carriers (II:3, II:11, III:2 and III:12) and four male patients (III:6, III:16, IV:1 and IV:2) in the pedigree harboured the duplication demonstrating that it was maternally inherited. The dual signal of Xq28 region in patient III:16 confirmed that the patient harbors a <italic>MECP2</italic> duplication rather than a triplication (Fig. <xref ref-type="fig" rid="Fig2">2c</xref>). Considering that tandem arrangement is the common form of <italic>MECP2</italic> duplication, we tried to amplify the junction fragment using the breakpoint-specific primers. However, we were unable to map out the sequence feature due to the enriched repeat in this region.<fig id="Fig2"><label>Fig. 2</label><caption><p>
<italic>MECP2</italic> duplication was identified using aCGH or FISH. <bold>a</bold> Result of aCGH (Agilent 4 × 180 K) in patient III:16. It shows a clinically significant 550 kb duplication at Xq28 (chrX:153,056,054–153,606,328 in the hg19). The duplication at Xq28 region contains 24 genes, including <italic>MECP2</italic>, <italic>IRAK1, L1CAM, AVPR2, NAA10, HCFC1</italic>, etc. <bold>b</bold> Results from custom chip (Agilent 8 × 60 K) in IV:1. The ratio (log2 is between 0.5–1.2) suggests that IV:1 carried <italic>MECP2</italic> duplication, not triplication. <bold>c</bold> The result from FISH in III:16. It shows two green signals (Xq28, <italic>MECP2</italic> probe) and one red signal (Xq22.31, STS probe)</p></caption><graphic id="MO2" xlink:href="12881_2017_486_Fig2_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec9">
<title>Skewed XCI patterns and inter-chromosomal homologous recombination during <italic>MECP2</italic> and <italic>AR</italic> region</title>
<p id="Par32">Analysis of XCI patterns on all the female family members (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2) showed that the XCI patterns in the female non-carriers were all random (II:9 and III:5), but that of the female carriers were all skewed (II:3, II:11, III:2 and III:12). However, the predominantly inactivated allele of <italic>AR</italic> gene in two female carriers from the same core family (II:3 and II:11) was not the same. II:3 had inactivated maternally inherited allele-279 while II:11 had inactivated maternally inherited allele-285 (Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2B, C). Accordingly, we tested for the alleles of <italic>AR</italic> gene in all male patients (III:6, III:16, IV:1 and IV:2) and found that the male patients did not carry the same allele. More importantly, two male patients from the same core family (brothers IV:1 and IV:2) carried different maternally inherited alleles (IV:1 carried allele-293 and IV:2 carried allele-274, see Additional file <xref ref-type="media" rid="MOESM2">2</xref>: Figure S2A). On the basis of above data, we inferred that the inter-chromosomal homologous recombination occurred on the <italic>MECP2-</italic>duplication region.</p>
<p id="Par33">In order to validate the occurrence of homologous recombination in the <italic>MECP2</italic> region, we chose the <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">microsatellite</ext-link> 23 × GT within the <italic>MECP2</italic> gene as the marker for <italic>MECP2</italic> duplication. We found that allele-292 of <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">microsatellite</ext-link> 23 × GT was shared by all of the <italic>MECP2</italic> duplication carriers (Additional file <xref ref-type="media" rid="MOESM3">3</xref>: Figure S3), which highlighted the close linkage of <italic>MECP2</italic> duplication to allele-292. Furthermore, after analyzing the relationship between <italic>AR</italic>-specific and <italic>MECP2</italic>-specific microsatellites in every family member, we inferred that the <italic>MECP2-</italic>duplication allele was exchanged with <italic>MECP2</italic>-normal allele by inter-chromosomal homologous recombination during <ext-link ext-link-type="uri" xlink:href="https://en.wikipedia.org/wiki/Meiosis">meiosis</ext-link>, resulting in different <ext-link ext-link-type="uri" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTrackUi?hgsid=471331129_hmUSv7M5VOhrcOTAnU5le7hhaUm9&amp;c=chrX&amp;g=microsat">microsatellite</ext-link> of <italic>AR</italic> gene in the <italic>MECP2-</italic>duplication allele (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). This proved that there has been three separate <italic>MECP2</italic> recombination events which occurred during three maternal transmissions (specifically, II:3 and II:11 from I:2; III:5 and III:6 from II:3; and IV:1and IV:2 from III:2).<fig id="Fig3"><label>Fig. 3</label><caption><p>The model for the inter-chromosomal homologous recombination in the <italic>MECP2-</italic>duplication allele</p></caption><graphic id="MO3" xlink:href="12881_2017_486_Fig3_HTML"></graphic></fig>
</p>
</sec>
</sec>
<sec id="Sec10">
<title>Discussion</title>
<p id="Par34">Methyl-CpG binding protein 2 (MECP2) is a transcriptional repressor that functions by binding directly to methylated CpG dinucleotides and recruiting co-repressor proteins such as histone deacetylases and Sin3a to the promoters of target genes [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. <italic>MECP2</italic> duplication syndrome refers to the duplication of <italic>MECP2</italic> which is located at Xq28. <italic>MECP2</italic> duplication syndrome was first described in a pedigree with five male patients presenting with severe intellectual disability in 1997 [<xref ref-type="bibr" rid="CR32">32</xref>]. It was then recognized as a disorder of genomic imbalance using real-time PCR in 2005 [<xref ref-type="bibr" rid="CR4">4</xref>]. <italic>MECP2</italic> duplication is now recognized as one cause of neurodevelopmental disorders. The genomic copy variant evaluation study from more than 700 patients with unexplained mental retardation suggested the prevalence of the <italic>MECP2</italic> duplication syndrome in male and female patients is approximately 1 and 0.3%, respectively [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par35">As a rare and severe genomic imbalance disorder, <italic>MECP2</italic> duplication syndrome is characterized by a broad range of neurodevelopmental abnormalities (severe intellectual disability, developmental delay, seizure, speech delay/deficit, ASD), as well as hypotonia, recurrent respiratory infections, and facial dysmorphism [<xref ref-type="bibr" rid="CR11">11</xref>]. Recently, Lim et al. examined 56 cases (49 males and 7 females) with <italic>MECP2</italic> duplication syndrome and expanded the phenotypic spectrum of this syndrome, such as scoliosis and gastrointestinal problems [<xref ref-type="bibr" rid="CR33">33</xref>]. Two Chinese patients with <italic>MECP2</italic> duplication have been reported previously, and they showed that Chinese patients present similarly as patients in western counties [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. However, these reports have only studied small pedigrees, and do not contain enough information to help Chinese pediatricians distinguish patients with <italic>MECP2</italic> duplication syndrome from patients with other unknown neurodevelopmental disorders. In this study, we described the detailed clinical and molecular genetic characteristics of a Chinese familial <italic>MECP2</italic> duplication. After testing all available members, we identified nine family members with <italic>MECP2</italic> duplication. Although the DNA of patient III:15 was not available for testing, his clinical characteristics and family-based linkage analysis suggested he had <italic>MECP2</italic> duplications syndrome too. It is one of the largest pedigrees of familial <italic>MECP2</italic> duplication, and is the largest Chinese pedigree thus far. This pedigree includes five male patients and four asymptomatic female carriers.</p>
<p id="Par36">We reviewed 17 related publications on <italic>MECP2</italic> duplication syndrome and analyzed the prevalence of major medical issues from 179 male patients (See Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>–<xref ref-type="bibr" rid="CR24">24</xref>]. Core symptoms of <italic>MECP2</italic> duplication syndrome include developmental delay (100%), severe intellectual disability (99.4%), hypotonia (93.4%), ASD or autistic feature (73.2%), recurrent infections (72.6%), and seizure/epilepsy (59.9%). All male patients in this Chinese family presented with the above major symptoms (See Table <xref ref-type="table" rid="Tab1">1</xref>). The consistent neurodevelopmental trajectory and facial dysmorphism in these five male patients further delineated clinical description and molecular genetic characterization of Chinese <italic>MECP2</italic> duplication syndrome. In addition, seizure was reported for the first time in a patient of Chinese Han ethinicity. In particular, four out of the five (4/5, 80%) male patients presented generalized tonic–clonic seizure.</p>
<p id="Par37">After reviewing all case reports on <italic>MECP2</italic> duplication syndrome published during last 5 years, only four male patients were reported to have survived beyond 25 years [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. Patient III:6 in our study has survived past 25 years old. He did not present any differently than the patients who have died younger. Continuous clinical interviews and physical/neurodevelopmental evaluations will be performed on him in the future, so that we can learn about the natural pathogenic progression of <italic>MECP2</italic> duplication syndrome. Of note, there have been reports of patients with <italic>MECP2</italic> triplication [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. The major clinical manifestations of <italic>MECP2</italic> triplication syndrome are similar to that of <italic>MECP2</italic> duplication syndrome except for the additional symptom of macrocephaly. Fittingly, male patients in this study did not present with macrocephaly.</p>
<p id="Par38">The majority of <italic>MECP2</italic> duplication are inherited, de novo mutations are rare [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Most cases are inherited maternally; paternal inheritance is exceedingly rare, and there have been only four reported cases of paternal inheritance, in which the male patients inherited the gene duplication from an unbalanced X/Y translocation [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. As an X-linked disorder, males are predominantly affected. Females with one copy of <italic>MECP2</italic> duplication are usually asymptomatic carriers as XCI is often skewed and preferentially inactivates the duplication-bearing X chromosome [<xref ref-type="bibr" rid="CR11">11</xref>]. However, female patients with <italic>MECP2</italic> duplication have been reported sporadically [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. The molecular genetic pathogenesis of symptomatic female patients included 1) unbalanced translocation between X chromosome and autosome, 2) no skewing of X-chromosome inactivation and 3) skewed XCI where the normal chromosome is preferentially inactivated [<xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. The symptoms in affected females are the same as those in affected males [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. In our study, female patient (IV:4) presented with some symptoms of <italic>MECP2</italic> duplication syndrome as the five male patients. She died at the age of 2 years and 10 days. Given the similarities in the clinical presentation and early death, we believe that she was an affected patient although no sample was available for genetic testing. We speculate that the skewed XCI on the normal X chromosome caused her to be symptomatic.</p>
<p id="Par39">Differential methylation at the 5′ portions of genes on X chromosome is considered to be one of the primary factors involved in XCI [<xref ref-type="bibr" rid="CR29">29</xref>]. The human <italic>AR</italic> gene is usually selected as the marker for XCI because it is unique in having a (CAG)n repeat in exon 1, and is highly pleomorphic, with a heterozygosity of 90%. However, <italic>AR</italic> gene is located at Xq12, which is 90 Mb away from <italic>MECP2</italic> region, located at Xq28, and the homologous recombination or crossover between the parental alleles can occur during meiosis. As a result of the inter-chromosomal homologous recombination in <italic>MECP2</italic> region, the (CAG)n repeat marker of <italic>AR</italic> gene is not consistent with that of <italic>MECP2-</italic>duplication allele in offspring. Our study confirmed three recombination events for the <italic>MECP2</italic>-duplication allele during maternal transmission due to homologous recombination. Therefore, we should be careful not to ignore inter-chromosomal homologous recombination when studying a gene located on Xq28 (like <italic>MECP2</italic>) while using <italic>AR</italic> gene as a marker for XCI.</p>
</sec>
<sec id="Sec11">
<title>Conclusions</title>
<p id="Par40">We described the detailed clinical and genetic characterization of a large Chinese family with familial <italic>MECP2</italic> duplication syndrome. The consistency in clinical presentation in affected family members delineate the typical phenotype of this genomic disorder in Chinese population, which include severe intellectual disability, ASD, seizures, respiratory infections, and constipation. Our report will help clinical neurologists recognize the disorder and distinguish it from other unknown neurodevelopment disorders. Meanwhile, although we described the clinical history for each of our patients, the few <italic>MECP2</italic> duplication cases reported from China are insufficient to allow comparison of phenotypes between Asian and Caucasian patients. Collaboration between countries and regions is urgently needed in order to study the natural history of rare diseases such as <italic>MECP2</italic> duplication on a global scale [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
</sec>
<sec sec-type="supplementary-material">
<title>Additional files</title>
<sec id="Sec12">
<p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="12881_2017_486_MOESM1_ESM.pdf"><label>Additional file 1: Figure S1.</label><caption><p> The MLPA result of the family members. (PDF 263 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="12881_2017_486_MOESM2_ESM.pdf"><label>Additional file 2: Figure S2.</label><caption><p> X-chromosome inactivation results analyzed using (CAG)n STR of <italic>AR</italic> gene. (PDF 221 kb)</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="12881_2017_486_MOESM3_ESM.pdf"><label>Additional file 3: Figure S3.</label><caption><p> The results for microsatellite 23 × GT of <italic>MECP2</italic> gene. (PDF 182 kb)</p></caption></media></supplementary-material>
</p>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>aCGH</term>
<def>
<p id="Par5">Array comparative genomic hybridization</p>
</def>
</def-item>
<def-item>
<term>
<italic>AR</italic>
</term>
<def>
<p id="Par6">Androgen receptor</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par7">Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>CNVs</term>
<def>
<p id="Par8">Copy number variants</p>
</def>
</def-item>
<def-item>
<term>FISH</term>
<def>
<p id="Par9">Fluorescent in situ hybridization</p>
</def>
</def-item>
<def-item>
<term>
<italic>MECP2</italic>
</term>
<def>
<p id="Par10">Methyl-CpG-binding protein 2 gene</p>
</def>
</def-item>
<def-item>
<term>MLPA</term>
<def>
<p id="Par11">Multiplex Ligand-dependant Probe amplification</p>
</def>
</def-item>
<def-item>
<term>SNVs</term>
<def>
<p id="Par12">Single nucleotide variants</p>
</def>
</def-item>
<def-item>
<term>XCI</term>
<def>
<p id="Par13">X-Chromosome inactivation</p>
</def>
</def-item>
<def-item>
<term>XLID</term>
<def>
<p id="Par14">X-linked intellectual disability</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Electronic supplementary material</bold>
</p>
<p>The online version of this article (10.1186/s12881-017-0486-4) contains supplementary material, which is available to authorized users.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>We sincerely thank all the family members who contributed to the study. We appreciate Sydney Song, the MD/PhD Candidate of Case Western Reserve University for her help in editing the manuscript.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par41">This work is partially funded by the Capital Health Research and Development of Special (2014-2-1131), the National Nature Science Fund [81100841, 81370708 and 31671310 to XLC, 81401207 to Hua Xie], Beijing Nature Science Fund [7162029 to XLC], the advanced Personnel Training Program of Beijing Municipal Health Bureau to XLC, Beijing nova program interdisciplinary collaborative project (xxjc201717) to XLC.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par42">The data that support the findings are all available in this published article and its supplementary information files.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>XLC designed the study, XYL, HX, XLC and JW performed DNA extraction, array experiment, MLPA, STR genotyping and data analysis, XYL, XLC and HX performed manuscript writing. JW analyzed and interpreted of data of FISH. QC, XYY, ZSY, EZL and JMZ helped in patients and family members’ recruitment and clinical checkup and obtained a genetics questionnaire. TZ gave key suggestions for design and manuscript writing. All authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par43">All research was approved by the ethics committee of Capital Institute of Pediatrics (SHERLL 2015069). The participants or the guardian/parent/next of kin on behalf of the minors under the age of 16 signed informed consent forms.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par44">The written informed consent was obtained from the participants or the patients’ guardian/parent/next of kin for the publication of related clinical information and images.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par45">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par46">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassani</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zapata</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gerosa</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moretto</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Murru</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Passafaro</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The neurobiology of X-linked intellectual disability</article-title>
<source/>The Neuroscientist
          <year>2013</year>
<volume>19</volume>
<issue>5</issue>
<fpage>541</fpage>
<lpage>552</lpage>
<pub-id pub-id-type="doi">10.1177/1073858413493972</pub-id>
<pub-id pub-id-type="pmid">23820068</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gecz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shoubridge</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Corbett</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The genetic landscape of intellectual disability arising from chromosome X</article-title>
<source/>Trends Genet
          <year>2009</year>
<volume>25</volume>
<issue>7</issue>
<fpage>308</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="doi">10.1016/j.tig.2009.05.002</pub-id>
<pub-id pub-id-type="pmid">19556021</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Van den Veyver</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tran</surname>
<given-names>CQ</given-names>
</name>
<name>
<surname>Francke</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
</person-group>
<article-title>Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2</article-title>
<source/>Nat Genet
          <year>1999</year>
<volume>23</volume>
<issue>2</issue>
<fpage>185</fpage>
<lpage>188</lpage>
<pub-id pub-id-type="doi">10.1038/13810</pub-id>
<pub-id pub-id-type="pmid">10508514</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meins</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gerresheim</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Herchenbach</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hagedorn</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hameister</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of Rett syndrome</article-title>
<source/>J Med Genet
          <year>2005</year>
<volume>42</volume>
<issue>2</issue>
<fpage>e12</fpage>
<pub-id pub-id-type="doi">10.1136/jmg.2004.023804</pub-id>
<pub-id pub-id-type="pmid">15689435</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bauer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kolsch</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Kruger</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Unterwalder</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hameister</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>FM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Infectious and immunologic phenotype of MECP2 duplication syndrome</article-title>
<source/>J Clin Immunol
          <year>2015</year>
<volume>35</volume>
<issue>2</issue>
<fpage>168</fpage>
<lpage>181</lpage>
<pub-id pub-id-type="doi">10.1007/s10875-015-0129-5</pub-id>
<pub-id pub-id-type="pmid">25721700</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>MECP2 duplication syndrome in a Chinese family</article-title>
<source/>BMC Med Genet
          <year>2015</year>
<volume>16</volume>
<fpage>112</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-015-0264-0</pub-id>
<pub-id pub-id-type="pmid">26672597</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A case report of Chinese brothers with inherited MECP2-containing duplication: autism and intellectual disability, but not seizures or respiratory infections</article-title>
<source/>BMC Med Genet
          <year>2012</year>
<volume>13</volume>
<fpage>75</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-13-75</pub-id>
<pub-id pub-id-type="pmid">22909152</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauters</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ignatius</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Raynaud</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hollanders</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males</article-title>
<source/>Am J Hum Genet
          <year>2005</year>
<volume>77</volume>
<issue>3</issue>
<fpage>442</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1086/444549</pub-id>
<pub-id pub-id-type="pmid">16080119</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Honda</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Satomura</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Imoto</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Concomitant microduplications of MECP2 and ATRX in male patients with severe mental retardation</article-title>
<source/>J Hum Genet
          <year>2012</year>
<volume>57</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2011.131</pub-id>
<pub-id pub-id-type="pmid">22129561</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanchard</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Bader</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thome</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Omo-Griffith</surname>
<given-names>L</given-names>
</name>
<name>
<surname>del Gaudio</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A partial MECP2 duplication in a mildly affected adult male: a putative role for the 3′ untranslated region in the MECP2 duplication phenotype</article-title>
<source/>BMC Med Genet
          <year>2012</year>
<volume>13</volume>
<fpage>71</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-13-71</pub-id>
<pub-id pub-id-type="pmid">22883432</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Esch</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>MECP2 duplication syndrome</article-title>
<source/>Mol Syndromology
          <year>2012</year>
<volume>2</volume>
<issue>3–5</issue>
<fpage>128</fpage>
<lpage>136</lpage>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Arai</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Momosaki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Togawa</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>MECP2 duplication syndrome in both genders</article-title>
<source/>Brain Dev
          <year>2013</year>
<volume>35</volume>
<issue>5</issue>
<fpage>411</fpage>
<lpage>419</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2012.07.010</pub-id>
<pub-id pub-id-type="pmid">22877836</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramocki</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Tavyev</surname>
<given-names>YJ</given-names>
</name>
<name>
<surname>Peters</surname>
<given-names>SU</given-names>
</name>
</person-group>
<article-title>The MECP2 duplication syndrome</article-title>
<source/>Am J Med Genet A
          <year>2010</year>
<volume>152A</volume>
<issue>5</issue>
<fpage>1079</fpage>
<lpage>1088</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33184</pub-id>
<pub-id pub-id-type="pmid">20425814</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shimada</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Hirasawa</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Yoshii</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tani</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Sugawara</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical manifestations of Xq28 functional disomy involving MECP2 in one female and two male patients</article-title>
<source/>Am J Med Genet A
          <year>2013</year>
<volume>161A</volume>
<issue>7</issue>
<fpage>1779</fpage>
<lpage>1785</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35975</pub-id>
<pub-id pub-id-type="pmid">23704079</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vignoli</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Borgatti</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Peron</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zucca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Ballarati</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bonaglia</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Electroclinical pattern in MECP2 duplication syndrome: eight new reported cases and review of literature</article-title>
<source/>Epilepsia
          <year>2012</year>
<volume>53</volume>
<issue>7</issue>
<fpage>1146</fpage>
<lpage>1155</lpage>
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03501.x</pub-id>
<pub-id pub-id-type="pmid">22578097</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trobaugh-Lotrario</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lopez-Terrada</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Hepatoblastoma in a male with MECP2 duplication syndrome</article-title>
<source/>Am J Med Genet A
          <year>2016</year>
<volume>170</volume>
<issue>3</issue>
<fpage>790</fpage>
<lpage>791</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.37474</pub-id>
<pub-id pub-id-type="pmid">26602209</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caumes</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Boespflug-Tanguy</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Villeneuve</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Delanoe</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leheup</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Late onset epileptic spasms is frequent in MECP2 gene duplication: electroclinical features and long-term follow-up of 8 epilepsy patients</article-title>
<source/>Eur J Paediatr Neurol
          <year>2014</year>
<volume>18</volume>
<issue>4</issue>
<fpage>475</fpage>
<lpage>481</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2014.03.005</pub-id>
<pub-id pub-id-type="pmid">24703762</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Fernandez</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lazarou</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Fallon</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>MECP2 triplication in 3 brothers - a rarely described cause of familial neurological regression in boys</article-title>
<source/>Eur J Paediatr
          <year>2012</year>
<volume>16</volume>
<issue>2</issue>
<fpage>209</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejpn.2011.07.011</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Nunez-Torres</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gonzalez-Meneses</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Antinolo</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Borrego</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Novel association of severe neonatal encephalopathy and Hirschsprung disease in a male with a duplication at the Xq28 region</article-title>
<source/>BMC Med Genet
          <year>2010</year>
<volume>11</volume>
<fpage>137</fpage>
<pub-id pub-id-type="doi">10.1186/1471-2350-11-137</pub-id>
<pub-id pub-id-type="pmid">20860806</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peters</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Hundley</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Vehorn</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Carvalho</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The behavioral phenotype in MECP2 duplication syndrome: a comparison with idiopathic autism</article-title>
<source/>Autism Res
          <year>2013</year>
<volume>6</volume>
<issue>1</issue>
<fpage>42</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1002/aur.1262</pub-id>
<pub-id pub-id-type="pmid">23169761</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fukushi</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Nomura</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Naiki</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kimura</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>Y</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical characterization and identification of duplication breakpoints in a Japanese family with Xq28 duplication syndrome including MECP2</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>4</issue>
<fpage>924</fpage>
<lpage>933</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36373</pub-id>
<pub-id pub-id-type="pmid">24478188</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Chuang</surname>
<given-names>TP</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>YW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo MECP2 duplication derived from paternal germ line result in dysmorphism and developmental delay</article-title>
<source/>Gene
          <year>2014</year>
<volume>533</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.10.001</pub-id>
<pub-id pub-id-type="pmid">24129071</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neira</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Romero-Espinoza</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rojas-Martinez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ortiz-Lopez</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cordova-Fletes</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Plaja</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo MECP2 disomy in a Mexican male carrying a supernumerary marker chromosome and no typical Lubs syndrome features</article-title>
<source/>Gene
          <year>2013</year>
<volume>524</volume>
<issue>2</issue>
<fpage>381</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.1016/j.gene.2013.04.029</pub-id>
<pub-id pub-id-type="pmid">23639959</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Palma</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Boniver</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cassina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Toldo</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Nosadini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clementi</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Eating-induced epileptic spasms in a boy with MECP2 duplication syndrome: insights into pathogenesis of genetic epilepsies</article-title>
<source/>Epileptic Disord
          <year>2012</year>
<volume>14</volume>
<issue>4</issue>
<fpage>414</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="pmid">23248047</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Gadi</surname>
<given-names>IK</given-names>
</name>
<name>
<surname>Labreche</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rehder</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromosomal microarray analysis in clinical evaluation of neurodevelopmental disorders-reporting a novel deletion of SETDB1 and illustration of counseling challenge</article-title>
<source/>Pediatr Res
          <year>2016</year>
<volume>80</volume>
<issue>3</issue>
<fpage>371</fpage>
<lpage>381</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2016.101</pub-id>
<pub-id pub-id-type="pmid">27119313</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>XL</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>LW</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>XY</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genomic copy number variations in children with unexplained mental retardation and developmental delay detected by array-comparative genomic hybridization. Chinese journal of evidence-based</article-title>
<source/>Pediatrics
          <year>2010</year>
<volume>5</volume>
<issue>2</issue>
<fpage>85</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="pmid">20043741</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Q</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Chromosomal microarray analysis of 2000 pediatric cases. Chinese</article-title>
<source/>J Med Genet
          <year>2016</year>
<volume>33</volume>
<issue>2</issue>
<fpage>247</fpage>
<lpage>251</lpage>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>BL</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Microarray-based genomic DNA profiling technologies in clinical molecular diagnostics</article-title>
<source/>Clin Chem
          <year>2009</year>
<volume>55</volume>
<issue>4</issue>
<fpage>659</fpage>
<lpage>669</lpage>
<pub-id pub-id-type="doi">10.1373/clinchem.2008.112821</pub-id>
<pub-id pub-id-type="pmid">19233918</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allen</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Zoghbi</surname>
<given-names>HY</given-names>
</name>
<name>
<surname>Moseley</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Rosenblatt</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>JW</given-names>
</name>
</person-group>
<article-title>Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation</article-title>
<source/>Am J Hum Genet
          <year>1992</year>
<volume>51</volume>
<issue>6</issue>
<fpage>1229</fpage>
<lpage>1239</lpage>
<pub-id pub-id-type="pmid">1281384</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Veenstra</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Wade</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Vermaak</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kass</surname>
<given-names>SU</given-names>
</name>
<name>
<surname>Landsberger</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription</article-title>
<source/>Nat Genet
          <year>1998</year>
<volume>19</volume>
<issue>2</issue>
<fpage>187</fpage>
<lpage>191</lpage>
<pub-id pub-id-type="doi">10.1038/561</pub-id>
<pub-id pub-id-type="pmid">9620779</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Laherty</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Eisenman</surname>
<given-names>RN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex</article-title>
<source/>Nature
          <year>1998</year>
<volume>393</volume>
<issue>6683</issue>
<fpage>386</fpage>
<lpage>389</lpage>
<pub-id pub-id-type="doi">10.1038/30764</pub-id>
<pub-id pub-id-type="pmid">9620804</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pai</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Hane</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Hammond</surname>
<given-names>LS</given-names>
</name>
<name>
<surname>Arena</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A new X linked recessive syndrome of mental retardation and mild dysmorphism maps to Xq28</article-title>
<source/>J Med Genet
          <year>1997</year>
<volume>34</volume>
<issue>7</issue>
<fpage>529</fpage>
<lpage>534</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.34.7.529</pub-id>
<pub-id pub-id-type="pmid">9222958</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<mixed-citation publication-type="other">Lim Z, Downs J, Wong K, Ellaway C, Leonard H. Expanding the clinical picture of the MECP2 duplication syndrome. Clin Genet. 2016. 10.1111/cge.12814.</mixed-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>del Gaudio</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Scaglia</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Craigen</surname>
<given-names>WJ</given-names>
</name>
<name>
<surname>Glaze</surname>
<given-names>DG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males</article-title>
<source/>Genet Med
          <year>2006</year>
<volume>8</volume>
<issue>12</issue>
<fpage>784</fpage>
<lpage>792</lpage>
<pub-id pub-id-type="doi">10.1097/01.gim.0000250502.28516.3c</pub-id>
<pub-id pub-id-type="pmid">17172942</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fieremans</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bauters</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Belet</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Verbeeck</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Jansen</surname>
<given-names>AC</given-names>
</name>
<name>
<surname>Seneca</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo MECP2 duplications in two females with intellectual disability and unfavorable complete skewed X-inactivation</article-title>
<source/>Hum Genet
          <year>2014</year>
<volume>133</volume>
<issue>11</issue>
<fpage>1359</fpage>
<lpage>1367</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-014-1469-6</pub-id>
<pub-id pub-id-type="pmid">25037250</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Auber</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Burfeind</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Thiels</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Alsat</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Shoukier</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liehr</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>An unbalanced translocation resulting in a duplication of Xq28 causes a Rett syndrome-like phenotype in a female patient</article-title>
<source/>Clin Genet
          <year>2010</year>
<volume>77</volume>
<issue>6</issue>
<fpage>593</fpage>
<lpage>597</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2009.01363.x</pub-id>
<pub-id pub-id-type="pmid">20236119</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sanlaville</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Prieur</surname>
<given-names>M</given-names>
</name>
<name>
<surname>de Blois</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Genevieve</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lapierre</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Ozilou</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional disomy of the Xq28 chromosome region</article-title>
<source/>Eur J Hum Genet
          <year>2005</year>
<volume>13</volume>
<issue>5</issue>
<fpage>579</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.1038/sj.ejhg.5201384</pub-id>
<pub-id pub-id-type="pmid">15741994</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scott Schwoerer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Laffin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haun</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Raca</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Friez</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Giampietro</surname>
<given-names>PF</given-names>
</name>
</person-group>
<article-title>MECP2 duplication: possible cause of severe phenotype in females</article-title>
<source/>Am J Med Genet A
          <year>2014</year>
<volume>164A</volume>
<issue>4</issue>
<fpage>1029</fpage>
<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36380</pub-id>
<pub-id pub-id-type="pmid">24458799</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<mixed-citation publication-type="other">Louise S, Fyfe S, Bebbington A, Bahi-Buisson N, Anderson A, Pineda M, et al. InterRett, a model for international data collection in a rare genetic disorder. Res Autism Spectr Disord. 2009;3(3)</mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>